PAVMED INC. (NASDAQ:PAVM) Files An 8-K Regulation FD Disclosure
Attached as exhibit 99.1 to this Current Report, is a press release dated April 24, 2019, issued by PAVmed Inc. (the Company), providing an update on certain product developments.
The information furnished under this Item 7.01 shall not be deemed filed for purpose of Section 18 of the Securities Exchange Act of 1934 nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document.
PAVmed Inc. Exhibit
EX-99.1 2 ex99-1.htm PAVmed Reports Excellent DisappEAR™ Animal Study Results Resorbable pediatric ear tube expected to benefit up to one million U.S. children per year NEW YORK,…
To view the full exhibit click